Announcements
Sidley Represents EDBI in Automera’s US$16M Series A Financing
October 2, 2023
Sidley represented EDBI in its investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs), in its US$16M Series A financing round.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
Contacts
Offices
Capabilities
Suggested News & Insights
The Wait is Over: SEC Proposes “Regulation Crypto Assets,” A Bespoke Offering Regime for Crypto Investment ContractsAugust 20, 2026Sidley Represents Clearlake Capital Group in Its Investment in Databricks’ US$5 Billion Funding RoundAugust 19, 2026Sidley Represents FormX in Its US$12.5 Million Series Seed FinancingAugust 11, 2026Sidley Represents Sapiom in US$35 Million Series A FinancingAugust 5, 2026Sidley Represents CAIS in Its US$170 Million Series D FinancingJuly 29, 2026Sidley Represents Jane Street in Its Investments in AI Chip Maker EtchedJuly 27, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory